SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Elevance Health Inc. (ANTM) 当前追踪市盈率 (P/E) 为 19.1. 追踪盈利收益率为 5.22%.
本页证实的标准:
- VALUE (67/100, 通过) — 市盈率低于市场平均水平 (19.1); 盈利收益率超过债券收益率 (5.22%).
- 追踪盈利收益率 5.22% — 超过典型债券收益率（约4.3%），使股票相对固定收益更具吸引力。
- 分析师共识目标价 $529.05 (+9.6% 上行空间) — 预期温和上涨。
SharesGrow 综合评分： 72/100 其中 5/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
67/100
Price-to-Earnings & upside
Proven by this page
✓
健康
100/100
Debt-to-Equity & liquidity
→ Health
估值概览 — ANTM
估值倍数
P/E (TTM)19.1
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.59
EV/EBITDA0.0
每股数据
EPS (TTM)$25.21
每股账面价值$0.00
每股营收$818.10
每股自由现金流$0.00
收益率与内在价值
盈利收益率5.22%
股息收益率0.00%
分析师目标价$529.05 (+9.6%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$9.21 |
$84.98B |
$2.47B |
2.9% |
| 2017 |
$14.35 |
$90.04B |
$3.84B |
4.3% |
| 2018 |
$14.19 |
$92.11B |
$3.75B |
4.1% |
| 2019 |
$18.47 |
$104.21B |
$4.81B |
4.6% |
| 2020 |
$17.98 |
$121.87B |
$4.57B |
3.8% |
| 2021 |
$24.73 |
$138.64B |
$6.1B |
4.4% |
| 2022 |
$24.28 |
$156.6B |
$5.89B |
3.8% |
| 2023 |
$25.22 |
$171.34B |
$5.99B |
3.5% |
| 2024 |
$25.68 |
$176.81B |
$5.98B |
3.4% |
| 2025 |
$25.21 |
$199.13B |
$5.66B |
2.8% |
